Latest Insider Transactions at Rx Sight, Inc. (RXST)
This section provides a real-time view of insider transactions for Rx Sight, Inc. (RXST). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of RxSight, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of RxSight, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 01
2023
|
Jesse Anderson Corley |
BUY
Grant, award, or other acquisition
|
Direct |
5,731
+16.0%
|
-
|
|
May 26
2023
|
Bakker Juliet Tammenoms |
BUY
Other acquisition or disposition
|
Direct |
33,135
+34.89%
|
-
|
|
May 26
2023
|
Bakker Juliet Tammenoms |
SELL
Other acquisition or disposition
|
Indirect |
497,150
-25.0%
|
-
|
|
May 11
2023
|
William J Phd Link |
BUY
Other acquisition or disposition
|
Indirect |
98,715
+12.45%
|
-
|
|
May 11
2023
|
William J Phd Link |
SELL
Other acquisition or disposition
|
Indirect |
258,390
-100.0%
|
-
|
|
Feb 10
2023
|
Bakker Juliet Tammenoms |
BUY
Open market or private purchase
|
Indirect |
480,000
+32.88%
|
$5,760,000
$12.5 P/Share
|
|
Feb 10
2023
|
Ronald M Md Kurtz President & CEO |
BUY
Grant, award, or other acquisition
|
Direct |
40,000
+50.0%
|
$480,000
$12.5 P/Share
|
|
Jan 19
2023
|
Tamara Fountain |
BUY
Grant, award, or other acquisition
|
Direct |
23,508
+32.75%
|
-
|
|
Nov 09
2022
|
William J Phd Link |
BUY
Other acquisition or disposition
|
Indirect |
107,236
+15.26%
|
-
|
|
Nov 09
2022
|
William J Phd Link |
SELL
Other acquisition or disposition
|
Indirect |
316,694
-55.07%
|
-
|
|
Aug 10
2022
|
William J Phd Link |
BUY
Other acquisition or disposition
|
Indirect |
107,236
+18.01%
|
-
|
|
Aug 10
2022
|
William J Phd Link |
SELL
Other acquisition or disposition
|
Indirect |
316,694
-35.51%
|
-
|
|
Jun 08
2022
|
William J Phd Link |
BUY
Other acquisition or disposition
|
Indirect |
126,979
+25.0%
|
-
|
|
Jun 08
2022
|
William J Phd Link |
SELL
Other acquisition or disposition
|
Indirect |
375,000
-29.6%
|
-
|
|
Jun 02
2022
|
Julie Andrews |
BUY
Grant, award, or other acquisition
|
Direct |
8,624
+18.65%
|
-
|
|
Jun 02
2022
|
Jesse Anderson Corley |
BUY
Grant, award, or other acquisition
|
Direct |
10,349
+29.82%
|
-
|
|
Jun 02
2022
|
William J Phd Link |
BUY
Grant, award, or other acquisition
|
Direct |
10,349
+17.9%
|
-
|
|
Jun 02
2022
|
Shweta Maniar |
BUY
Grant, award, or other acquisition
|
Direct |
4,312
+15.5%
|
-
|
|
Jun 02
2022
|
Robert J Palmisano |
BUY
Grant, award, or other acquisition
|
Direct |
8,624
+28.16%
|
-
|
|
Jun 02
2022
|
Bakker Juliet Tammenoms |
BUY
Grant, award, or other acquisition
|
Direct |
10,349
+26.5%
|
-
|
|
Jun 02
2022
|
Robert Keith Warner |
BUY
Grant, award, or other acquisition
|
Direct |
8,624
+28.16%
|
-
|
|
May 17
2022
|
William J Phd Link |
SELL
Other acquisition or disposition
|
Indirect |
375,000
-22.84%
|
-
|
|
Mar 15
2022
|
William J Phd Link |
SELL
Other acquisition or disposition
|
Indirect |
375,000
-18.59%
|
-
|
|
Jan 03
2022
|
Shweta Maniar |
BUY
Grant, award, or other acquisition
|
Direct |
19,196
+50.0%
|
-
|
|
Nov 17
2021
|
Jesse Anderson Corley |
BUY
Open market or private purchase
|
Direct |
8,150
+36.78%
|
$97,800
$12.48 P/Share
|
|
Aug 05
2021
|
Ilya Goldshleger |
BUY
Open market or private purchase
|
Indirect |
1,372
+50.0%
|
$17,836
$13.69 P/Share
|
|
Aug 05
2021
|
Ilya Goldshleger |
BUY
Open market or private purchase
|
Direct |
1,000
+50.0%
|
$14,000
$14.49 P/Share
|
|
Aug 05
2021
|
Eric Weinberg |
BUY
Open market or private purchase
|
Indirect |
9
+0.96%
|
$126
$14.9 P/Share
|
|
Aug 05
2021
|
Ronald M Md Kurtz President & CEO |
BUY
Open market or private purchase
|
Indirect |
3,638
+0.45%
|
$47,294
$13.85 P/Share
|
|
Aug 04
2021
|
Eric Weinberg |
BUY
Open market or private purchase
|
Indirect |
615
+40.17%
|
$9,840
$16.25 P/Share
|
|
Aug 03
2021
|
Eric Weinberg |
BUY
Open market or private purchase
|
Indirect |
1
+0.33%
|
$17
$17.03 P/Share
|
|
Aug 03
2021
|
Robert Keith Warner |
BUY
Open market or private purchase
|
Indirect |
43,750
+43.37%
|
$700,000
$16.0 P/Share
|
|
Aug 03
2021
|
Robert Keith Warner |
BUY
Grant, award, or other acquisition
|
Direct |
13,378
+43.18%
|
-
|
|
Aug 03
2021
|
Robert J Palmisano |
BUY
Grant, award, or other acquisition
|
Direct |
13,378
+43.18%
|
-
|
|
Aug 03
2021
|
Julie Andrews |
BUY
Open market or private purchase
|
Direct |
15,625
+35.01%
|
$250,000
$16.0 P/Share
|
|
Aug 03
2021
|
Julie Andrews |
BUY
Grant, award, or other acquisition
|
Direct |
13,378
+43.18%
|
-
|
|
Aug 03
2021
|
Ronald M Md Kurtz President & CEO |
BUY
Open market or private purchase
|
Direct |
125,000
+50.0%
|
$2,000,000
$16.0 P/Share
|
|
Aug 03
2021
|
Eric Weinberg |
BUY
Open market or private purchase
|
Direct |
31,250
+50.0%
|
$500,000
$16.0 P/Share
|
|
Aug 03
2021
|
William J Phd Link |
BUY
Open market or private purchase
|
Direct |
31,250
+45.71%
|
$500,000
$16.0 P/Share
|
|
Aug 03
2021
|
William J Phd Link |
BUY
Conversion of derivative security
|
Indirect |
2,016,778
+50.0%
|
-
|
|
Aug 03
2021
|
Jesse Anderson Corley |
BUY
Open market or private purchase
|
Indirect |
78,125
+15.19%
|
$1,250,000
$16.0 P/Share
|
|
Aug 03
2021
|
Bakker Juliet Tammenoms |
BUY
Open market or private purchase
|
Indirect |
625,000
+27.96%
|
$10,000,000
$16.0 P/Share
|
|
Aug 03
2021
|
Bakker Juliet Tammenoms |
BUY
Conversion of derivative security
|
Indirect |
1,863,613
+50.0%
|
-
|
|
Aug 03
2021
|
Bakker Juliet Tammenoms |
BUY
Open market or private purchase
|
Direct |
12,500
+40.51%
|
$200,000
$16.0 P/Share
|
|
Aug 03
2021
|
Bruce C Robertson Director |
BUY
Conversion of derivative security
|
Indirect |
1,385,037
+50.0%
|
-
|
|
Aug 03
2021
|
Daniel Mark Schwartz Director |
BUY
Conversion of derivative security
|
Direct |
3,969
+0.96%
|
-
|
|
Aug 03
2021
|
Richard M. Wolfen Director |
BUY
Conversion of derivative security
|
Indirect |
1,489,805
+45.81%
|
-
|
|
Aug 03
2021
|
Richard M. Wolfen Director |
BUY
Conversion of derivative security
|
Direct |
76,974
+49.61%
|
-
|
|
Aug 03
2021
|
Rx Sight I, LLC > 10% Shareholder |
BUY
Conversion of derivative security
|
Direct |
2,016,778
+50.0%
|
-
|
|
Aug 02
2021
|
Eric Weinberg |
BUY
Open market or private purchase
|
Indirect |
90
+23.08%
|
$1,530
$17.04 P/Share
|